 |
CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ |
| Journals - Contents | |
 |
 |
|
Transfuze a hematologie dnes |
||
|
Madžo J.1, 2, Mužíková K.1, Froňková E.1, Šrámková L.1, Zemanová L.1, Zuna J.1, Starý J.3, Trka J.1,*:
Is TEL/AML1 fusion gene appropriate marker for minimal residual disease monitoring in children with acute lymphoblastic leukaemia? |
137 |
|
Kuhrová V., Francová H., Klimešová D., Mayer J.:
Chronic lymphocytic leukemia: mutational status of the immunoglobulin heavy chain gene is a significant prognostic marker |
143 |
|
Doubek M.1, Řeháková K.2, Scheer P.2, Doubek J.2, Mayer J.1:
Immune-deficient mouse as a model for the study of leukaemias |
149 |
|
Pytlík R.1, Cmunt E.1, Kleibl Z.2, Kozák T.3:
Anagrelide in the treatment of essential thrombocythemia |
154 |
|
Neuwirtová R.:
Overview of conservative treatment of myelodysplastic syndrom over the twenty years and new drugs for the future |
161 |
Order this issue |
| | HOME PAGE | CODE PAGE | CZECH VERSION | |
| © 1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ |
| Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o. |
| WEBMASTER |